New research discovers a link between estrogen and pain receptors in the colon, which may explain higher rates and intensity of irritable bowel syndrome-related symptoms in women.
Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer. Findings from a recent clinical trial ...
Efficacy of subsequent treatments after disease progression on CDK4/6 inhibitors therapy in patients with hormone receptor-positive metastatic breast cancer: A Kaplan-Meier derived individual-patient ...
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common ...
Women are dramatically more likely than men to suffer from irritable bowel syndrome (IBS), a chronic condition causing abdominal pain, bloating, and digestive discomfort. Now, scientists at UC San ...
A mouse study suggests estrogen may increase gut pain by activating specific cells, offering hints to why IBS is more common ...
High-grade serous ovarian cancer remains a primary focus in gynecologic oncology; however, low-grade serous ovarian cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results